Download Curriculum vitae - Applied Science University

Feras Darwish El-Hajji, MSc., PhD.
Mobile No. 00962 79 5180 816
Email: [email protected]
Personal

Date of birth: Oct 1st, 1978

Nationality: Jordanian
Education

Ph.D Degree in Clinical Pharmacy / Pharmacy Practice from The School of Pharmacy, Queen’s
University Belfast (QUB), Northern Ireland – UK, March 2011.
The PhD thesis is entitled as “Application of risk assessment measures within enhanced clinical
pharmacy provision”.

MSc. Degree in Pharmaceutical Sciences from the University of Jordan, July 2006 – Thesis entitled
as: “Preparation and Evaluation of Glimepiride Rapidly Disintegrating Tablets”.

BSc. degree in Pharmacy from the Applied Science University, February 2002.
Professional Experience
 Chairman of Department of Pharmaceutical Sciences and Pharmaceutics at Faculty of Pharmacy,
Applied Science University in Amman, Jordan – Since September 2016.
 Working as an assistant professor (lecturer) in the Department of Clinical Pharmacy and
Therapeutics at Faculty of Pharmacy, Applied Science University in Amman, Jordan - Since March
2011. Teaching clinical pharmacy courses, i.e. Clinical Pharmacy and Therapeutics, Hospital
Pharmacy Practice, Clinical Biochemistry, Non-Prescription Drugs, Pharmacoeconomics, and
Pharmacology.
 Head of Clinical Pharmacy & Pharmaceutical Care Unit at Ibn Al-Haytham Hospital in Amman,
Jordan – October 2015 to September 2016.
 Chairman of Department of Clinical Pharmacy and Therapeutics at Faculty of Pharmacy, Applied
Science University in Amman, Jordan - From October 2013 to September 2015.
 A Visiting Research Fellow (Honorary Postdoc) at School of Pharmacy, Queen’s University Belfast
and Northern Health and Social Care Trust in Northern Ireland, UK – Starting from November
2012. The research is focusing on the Integrated Medicines Management (IMM) and the
antimicrobial stewardship program.
 A member in the “New Drugs Registration” committee in the Jordan Food and Drug Administration
(JFDA), starting from November 2012.
 Medical and Regulatory Affairs Consultant for Jordanian pharmaceutical companies.
 Head of Clinical Pharmacy & PharmD Committee at Jordan Pharmaceutical Association (JPA) From June 2014 to June 2015
 Worked in Research & Development (R&D) of Hikma Pharmaceuticals, Amman as a formulation
team-leader – From November 2002 to August 2007.
Job description included:
- Developing ANDA drug products for regulated market (US) and for Jordan and MENA markets.
- Supervising bioequivalence studies, and auditing dosing procedures.
- Bioequivalence study data assessment.
- Designing and supervising the manufacturing of the scale-up pilot batches and the first production
batch of each product.
- Participating in the team responsible for troubleshooting the issues related to formulation, scale-up,
manufacturing, stability, and bioequivalence.
- Auditing on documentation and FDA filing requirements.
Conferences











All conferences arranged by Faculty of Pharmacy in the Applied Science University.
March 2016: International Conference of Pharmacy and Health Sciences in Ipoh – Malaysia.
August 2014: International Social Pharmacy Workshop (ISPW) in Boston – USA.
April 2013: Oman Pharmaceutical Conference in Muscat – Oman.
November 2012: The 2nd MENA Biosimilars Conference in Amman - Jordan.
May 2012: Five Nations Health Protection Conference in Belfast - UK.
November 2011: Updates in Nutritional Management of Diabetics and Elderly Conference, at
Faculty of Agriculture, The University of Jordan - Jordan.
April 2010: The Health Services Research and Pharmacy Practice (HSRPP) Conference in
Manchester – UK.
March 2010: All Ireland Schools of Pharmacy Conference at Queen's University Belfast - UK
March 2009: Queen’s University Belfast postgraduates poster competition: Winning the 2nd prize in
Faculty of Medicine, Health and Life Sciences.
November 2008: 4th All Ireland Pharmacy Conference in Dundalk - Ireland.
Workshops
 Harmonization for Quality Assessment of Pharmaceuticals Workshop by the JFDA and USAID –
2015 Amman, Jordan.
 Clinical Data Evaluation “Reviewer Perspective” – 2014 Amman. Jordan.
 Drug Registration Workshop by the JFDA and WHO – 2013 Amman, Jordan.
 Academic Staff Preparatory Course – 2011 Amman, Jordan.
 Microsoft Office Skills – 2009 Belfast, UK and Clinical Research Workshop – 2009 Belfast, UK.
 Ethics in Research – 2008 Belfast, UK .
 BA/BE Studies – 2007 Amman, Jordan and Oral Communication Skills – 2007 Amman, Jordan.
 Colorcon Coating School – 2005 Milan, Italy.
 Strategic Presentation Seminar – 2003 Amman, Jordan.
 Professional Selling Skills III Programme – 2001 Amman, Jordan.
Publications
Mallah, EM., Rayyan, WSA., Dayyeh, WAA., D. Elhajji, F., Mansour, KA., Al-Majali, IS., Arafat,
TA. (2016) Dose-Dependent Synergistic effect of Pomegranate Juice on the Bioavailability of
Sildenafil in Rats by Using HPLC Method. Latin American Journal of Pharmacy, 35 (6): 1277-84.
Moh'd Salemaldajeh, Eyad Mallah, Riad Awad, Wael Abu Dayyih, Feras Darwish Elhajji, Israa
H. Al-ani, Basmah A. Othman and Tawfiq Arafat. (2015) Determination of carbamazepine in rat
plasma in the presence of licorice juice by using HPLC and its pharmacokinetic applications.
Journal of Chemical and Pharmaceutical Research, 2015, 7(12):116-26.
Darwish Elhajji, FW., Scullin, C., Scott, MG., McElnay, JC. (2015) Enhanced clinical pharmacy
service targeting tools: risk-predictive algorithms. Journal of Evaluation in Clinical Practice. 2015
Apr;21(2):187-97.
Darwish Elhajji, FW., Scott, MG., Aldeyab, MA., Kearney, MP., McElnay, JC. (2014) Clinical
pharmacy CDI patient clinical outcomes. Hospital Pharmacy Europe. 2014 Winter 76:28-30.
Abdelhadi, NN., Wazaify, M., Darwish Elhajji, FW., Basheti, IA., (2014) Doctor of Pharmacy in
Jordan: Students' Career Choices, Perceptions and Expectations. Journal of Pharmacy and Nutrition
Sciences. 2014, 4:213-9.
Aldeyab, MA., McElnay, JC., Scott, MG., Lattyak, WJ., Darwish Elhajji, FW., Aldiab, MA.,
Magee, FA., Conlon, G., Kearney, MP. (2013) A modified method for measuring antibiotic use in
healthcare settings: implications for antibiotic stewardship and benchmarking. The Journal of
Antimicrobial Chemotherapy. 2013 Nov 9:1-5.
Aldeyab, MA., McElnay, JC., Scott, MG., Darwish Elhajji, FW., Kearney, MP. (2013) Hospital
antibiotic use and its relationship to age-adjusted comorbidity and alcohol-based hand rub
consumption. Journal of Epidemiology and Infection. 2013 May 9:1-5.
Aldeyab, MA., Kearney, MP., Scott, MG., Aldiab, MA., Alahmadi, YM., Darwish Elhajji, FW.,
Magee, FA. and McElnay, JC. (2012) An evaluation of the impact of stewardship on reducing the
use of high-risk antibiotics and its effect on the incidence of Clostridium difficile in hospital
settings. Journal of Antimicrobial Chemotherapy, 2012 Dec;67(12):2988-96
Darwish Elhajji, FW., Scott, MG., Aldeyab, MA., Kearney, MP. and McElnay, JC. (2012) The
impact of clinical pharmacy services on Clostridium difficile infected patients’ length of stay in a
hospital in Northern Ireland. Five Nations Health Protection Conference.
Aldeyab, MA., Harbath, S., Vernaz, N., Kearney, MP., Scott, MG., Darwish Elhajji, FW., Aldiab,
MA. and McElnay, JC. (2012) The impact of antibiotic use on the incidence and resistance pattern
of extended-spectrum-beta-lactamase-producing bacteria in primary and secondary healthcare
settings. British Journal of Clinical Pharmacology, 74(1):171-9.
Aldeyab, M., McElnay, J., Scott, M., Davies, E., Edwards, C., Darwish Elhajji, F., Conlon, G.,
Magee, F., Barr, P. and Kearney, M. (2011) An evaluation of the impact of a single-dose
intravenous immunoglobulin regimen in the treatment of Clostridium difficile infections. Infection
Control and Hospital Epidemiology, 32(6), 631-3
Aldeyab, M., Devine, M., Flanagan, P., Mannion, M., Craig, A., Scott, M., Harbarth, S., Vernaz,
N., Davies, E., Brazier, J., Smyth, B., McElnay, J., Gilmore, B., Conlon, G., Magee, F., Darwish
Elhajji, F., Small, S., Edwards, C., Funston, C. and Kearney, M. (2011) Multihospital outbreak of
Clostridium difficile ribotype 027 infection: Epidemiology and analysis of control measures.
Infection Control and Hospital Epidemiology, 32(3), 210-9
Alahmadi, Y.M., Aldeyab, M.A., McElnay, J.C., Scott, M.G., Darwish Elhajji, F.W., Magee, F.A.,
Dowds, M., Edwards, C., Fullerton, L., Tate, A. and Kearney, M.P. (2011) Clinical and economic
impact of contaminated blood cultures within hospital setting. Journal of Hospital Infection, 77(3),
233-6.
Conlon, G., Aldeyab, M.A., McElnay, J.C., Scott, M.G., Magee, F.A., Davies, E., Gill, D., Darwish
Elhajji, F.W., Elshibly, S.M. and Kearney, M.P. (2011) Improving and maintaining adherence with
hospital antibiotic policies: A strategy of success. Journal of Hospital Infection, 77, 88-9.
Aly, A., Amro, B. and Darwish Elhajji, F. (2011) Preparation and evaluation of rapidly
disintegrating glimepiride tablets. International Journal of Pharmaceutical Sciences and
Nanotechnology, 3(4).
Darwish Elhajji, F., Scott, M.G., and McElnay, J.C. (2010) Measuring patients’ risk of hospital
readmission using the PARR++ tool as a clinical quality indicator. International Journal of
Pharmacy Practice, S1, 21-2.